Trial
NCT02894515
Bioequivalence Study of Idalopirdine in Healthy Subjects
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
H. Lundbeck A/S
Collaborators
—
Condition
Bioequivalence
Intervention
Idalopirdine commercial tablet (test)
Why stopped
The study was withdrawn based on new efficacy data from another study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-11-11